TechCrunch Disrupt 2026 Concludes in San Francisco, Bringing Together Over 10,000 Global Tech Leaders

The three-day conference brought together more than 10,000 global technology industry participants, highlighting artificial intelligence, venture capital, emerging technologies and startup innovation.

TechCrunch Disrupt 2026 concluded on October 15 at Moscone West in San Francisco, bringing together more than 10,000 founders, investors, executives and technology professionals for three days of startup competitions, industry discussions and networking.

Held from October 13–15, the conference featured more than 200 sessions and over 250 speakers, addressing developments in artificial intelligence, venture capital, enterprise technology and emerging industries. One of its central highlights was the Startup Battlefield competition, where biotechnology startup Intero Biosystems secured the $100,000 grand prize.

Intero Biosystems Wins Startup Battlefield 2026

Startup Battlefield remained a major attraction, providing early-stage companies with opportunities to showcase their technologies before venture capital investors and industry experts.

The competition featured 200 selected startups, with 20 advancing to live presentations. Five finalists—Apate, Flox Intelligence, Intero Biosystems, Industrial Next and Satlyt—competed for the top award.

Denver-based Intero Biosystems emerged as the winner, receiving the Startup Battlefield Cup and $100,000.

Founded by Charlie Childs and Madeline Eiken, the company develops laboratory-grown human intestinal tissue models designed to support pharmaceutical research and drug testing.

Its technology aims to help researchers better understand how substances interact with human intestinal tissue, potentially improving early-stage drug development.

The victory highlighted growing investor and industry interest in biotechnology and research-driven startups alongside artificial intelligence and software businesses.

Artificial Intelligence and Emerging Technologies Lead Discussions

Artificial intelligence was a dominant theme throughout TechCrunch Disrupt 2026, with discussions examining its expanding applications across enterprise software, robotics, cloud infrastructure and industrial systems.

The AI Stage, presented by Google Cloud, explored generative AI, autonomous agents and the commercial challenges associated with deploying AI-powered products.

Other sessions focused on AI infrastructure, energy requirements, advanced manufacturing and the integration of intelligent systems into physical environments.

Industry executives, including Rivian CEO RJ Scaringe, Cerebras Systems CEO Andrew Feldman and Replit CEO Amjad Masad, participated in the conference programme.

The discussions reflected a broader shift in the technology sector from developing AI models toward building practical applications, scalable infrastructure and commercially sustainable products.

Venture Capital and Startup Growth Take Center Stage

Fundraising and business development were also prominent topics, with founders and investors discussing early-stage financing, product-market fit, acquisitions and strategies for scaling technology companies.

Representatives from venture capital firms including Benchmark, Inspired Capital, Goodwater Capital and M13 participated in the event.

The Builders Stage offered practical insights into securing investment, developing revenue models and navigating the operational challenges of growing startups.

Beyond formal presentations, the conference provided networking opportunities through investor meetings, roundtables, exhibitions and startup showcases.

More than 320 exhibiting startups participated, allowing emerging companies to demonstrate their products and establish relationships with potential investors, customers and partners.

TechCrunch Disrupt Highlights Changing Startup Priorities

TechCrunch Disrupt 2026 demonstrated the increasingly diverse nature of the global startup ecosystem, with biotechnology, robotics, AI infrastructure and enterprise software attracting attention.

While artificial intelligence remained central to many discussions, Intero Biosystems’ victory illustrated the importance of scientific research and specialised technologies in creating new business opportunities.

The conference also reinforced San Francisco’s position as a major meeting point for entrepreneurs and venture capital investors.

For participating startups, the longer-term significance of the event will depend on whether the connections, exposure and industry feedback gained during the conference translate into investment, partnerships and sustainable business growth.